Empowering the Immune System to Prevent and Treat Disease
VBI’s pipeline is comprised of vaccine and immunotherapeutic programs developed by virus-like particle technologies to target two distinct, but often related, disease areas – infectious disease and oncology.
We prioritize disease targets that are challenging, underserved, and where the human immune system, when powered and stimulated appropriately, can be a formidable opponent.
Our pipeline is unified in the mission to achieve better health for all.
Learn more about our ongoing and completed clinical studies of investigational vaccine candidates.
Browse our library of publications to read more about our science and pipeline candidates.
